Recent Finacing
Recent Raise
Inception IBD develops therapeutics targeting IBD pathogenesis using genomic analysis of diseased tissue and Inserm‑licensed drug discovery tools, operating translational research programs in Montréal in collaboration with Celgene.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors